Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;28(5):2205-2215.
doi: 10.1007/s00520-019-05031-5. Epub 2019 Aug 19.

Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea

Affiliations

Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea

Komal Singh et al. Support Care Cancer. 2020 May.

Abstract

Purpose: Between 19 and 58% of oncology patients experience chemotherapy-induced nausea (CIN). In a sample of outpatients with breast, gastrointestinal (GI), gynecological, and lung cancer, the study purposes were to evaluate for inter-individual differences in the severity of CIN over two cycles of chemotherapy (CTX) and to determine which demographic and clinical characteristics and GI symptoms were associated with higher initial levels as well as with the trajectories of CIN severity.

Methods: Patients completed study questionnaires at six time points over two cycles of CTX. These questionnaires provided information on demographic and clinical characteristics, as well as the occurrence of twelve GI symptoms. Hierarchical linear modeling based on full maximum likelihood estimation was performed.

Results: Of the 1251 patients, 47.2% reported CIN. Across two cycles of CTX, lower functional status scores and higher levels of comorbidity were associated with higher initial levels of CIN. Younger age and emetogenicity of the CTX regimen were associated with higher initial levels as well as worse trajectories of CIN. The occurrence of five GI symptoms (i.e., vomiting, lack of appetite, constipation, feeling bloated, and difficulty swallowing) was associated with higher initial levels of CIN. The occurrence of mouth sores was associated with higher initial levels as well as with worst trajectories of CIN.

Conclusions: This study is the first to identify distinct demographic, clinical, and GI symptom characteristics associated with CIN severity. These findings suggest that the etiology of CIN is complex and may warrant interventions beyond standard antiemetics.

Keywords: Antiemetics; Cancer; Chemotherapy; Gastrointestinal symptoms; Hierarchical linear modeling; Nausea.

PubMed Disclaimer

Figures

Figure 1 A –
Figure 1 A –
Piecewise model of mean nausea scores for six assessments over two cycles of chemotherapy (CTX).
Figure 1 B -
Figure 1 B -
Spaghetti plot of individual nausea trajectories (QOL6) for a random sample of 50 patients over two cycles of CTX.
Figure 2
Figure 2
A-E- Influence of enrollment scores for Karnofsky Performance Status (KPS) score (A) and Self-Administered Comorbidity Questionnaire (SCQ) (B) on inter-individual differences in the intercept for nausea; the influence of child care responsibilities (C) on inter-individual differences in the slope parameter for nausea; and the influence of age (D) and emetogenicity of the chemotherapy regimen (E) on inter-individual differences in the intercept and slope parameters for nausea.
Figure 3
Figure 3
A-E Influence of vomiting (A), lack of appetite (B), constipation (C), feeling bloated (D), and difficulty swallowing (E) on inter-individual differences in the intercept for nausea and influence of mouth sores (F) on inter-individual differences in the intercept and slope parameters for nausea.

Similar articles

Cited by

References

    1. Aouizerat BE, Dodd M, Lee K, West C, Paul SM, Cooper BA, Wara W, Swift P, Dunn LB, Miaskowski C (2009) Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue Biol Res Nurs 11: 27–41 - PubMed
    1. Balaban CD, Yates BJ (2017) What is nausea? A historical Analysis of changing views Auton Neurosci 202: 5–17 - PMC - PubMed
    1. Bowen JM, White I, Smith L, Tsykin A, Kristaly K, Thompson SK, Karapetis CS, Tan H, Game PA, Irvine T, Hussey DJ, Watson DI, Keefe DM (2015) Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study Support Care Cancer 23: 3165–3172 - PubMed
    1. Dhruva A, Dodd M, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Swift PS, Wara W, Miaskowski C (2010) Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy Cancer Nurs 33: 201–212 - PMC - PubMed
    1. Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC (2016) Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis Support Care Cancer 24: 2635–2642 - PMC - PubMed